---
title: "Kyowa Kirin EMEA’s Crysvita approved by EC for infants with XLH"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293465135.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-22T09:41:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293465135.md)
  - [en](https://longbridge.com/en/news/293465135.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293465135.md)
generator: "portal-rs"
---

# Kyowa Kirin EMEA’s Crysvita approved by EC for infants with XLH

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [4151.JP](https://longbridge.com/en/quote/4151.JP.md)

## Related News & Research

- [How Cognizant’s AI-Powered Benchling Deployment at Kyowa Kirin (CTSH) Has Changed Its Investment Story](https://longbridge.com/en/news/296072336.md)
- [Kura Oncology posts corporate presentation on KOMZIFTI launch, ziftomenib pipeline strategy](https://longbridge.com/en/news/295714112.md)
- [Oppenheimer Asset Management Inc. Buys Shares of 29,022 Vita Coco Company, Inc. $COCO](https://longbridge.com/en/news/296083123.md)
- [Kyowa Kirin: Strong profit and revenue growth driven by global expansion and product performance](https://longbridge.com/en/news/294651137.md)
- [05:56 ETGrünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands](https://longbridge.com/en/news/277450231.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**